Carisma Therapeutics, Inc.
Carisma Therapeutics, Inc. (CARM) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CARM · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
4
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Carisma Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CARM insider buying and selling by quarter
CARM insider selling · CARM insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · CARM ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CARM executive sell shares · CARM board member insider trading · CARM insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 7, 2025 | Klichinsky Michael Chief Scientific Officer | Option | 56,982 | $6K | Form 4 |
| Oct 7, 2025 | Klichinsky Michael Chief Scientific Officer | Sale | 56,982 | $14K | Form 4 |
| Oct 1, 2025 | Klichinsky Michael Chief Scientific Officer | Sale | 165,000 | $42K | Form 4 |
| Oct 2, 2025 | Klichinsky Michael Chief Scientific Officer | Sale | 200,000 | $51K | Form 4 |
| Oct 3, 2025 | Klichinsky Michael Chief Scientific Officer | Sale | 119,347 | $31K | Form 4 |
Klichinsky Michael
Chief Scientific Officer
Date
Oct 7
Shares
56,982
Price
$0.11
Value
$6K
Klichinsky Michael
Chief Scientific Officer
Date
Oct 7
Shares
56,982
Price
$0.25
Value
$14K
Klichinsky Michael
Chief Scientific Officer
Date
Oct 1
Shares
165,000
Price
$0.26
Value
$42K
Klichinsky Michael
Chief Scientific Officer
Date
Oct 2
Shares
200,000
Price
$0.25
Value
$51K
Klichinsky Michael
Chief Scientific Officer
Date
Oct 3
Shares
119,347
Price
$0.26
Value
$31K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CARM insider trading
CARM insider trades
Carisma Therapeutics, Inc. (CARM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Klichinsky Michael (Chief Scientific Officer). Over the past 12 months, 1 insiders have filed transactions with the SEC. CARM insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Carisma Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CARM insider trading · 5 questionsThe insiders of Carisma Therapeutics, Inc. (CARM) include executives and directors such as Klichinsky Michael (Chief Scientific Officer), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026